drugset / Trial / NCT04579783

Corticosteroid and Repeated Dextrose Hydro-dissection for Carpal Tunnel Syndrome Patients

NCT04579783

RandomizedParallel-groupDouble-blindTreatment

Summary

Carpal tunnel syndrome (CTS) is the most prevalent peripheral nerve entrapment of upper limb. Typical symptoms comprise pain, numbness or tingling of the thumb and index, middle or ring fingers. Thumb weakness and decreased grip strength can occur in the later stage. Currently treatments included physical modalities (low power laser, transcutaneous electrical nerve stimulation, ultrasound), medication, splinting, injection and surgery. Ultrasound guided intracarpal hydro-dissection of median nerve had been proposed based on its accurate localization, while the injectates were diverse. Corticosteroid has been widely used for CTS for decades. However, growing evidences suggested that 5% dextrose, normal saline, platelet rich plasma injection also have therapeutic effects on alleviating CTS symptoms. Among the injectates, a single 5% dextrose injection could be considered as a substitute of corticosteroid based on its long term effect up to six months. However, the clinical efficacy of 5% dextrose injection has not validated by the further study. The investigators aim to compare the therapeutic effect of 5% dextrose injection with corticosteroid injection in patients with CTS, up to 12 weeks follow up.

Timeline

Start
2020-11-27
Primary completion
2022-10
Completion
2022-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator D5W Unknown 5 ml Other
Comparator Triamcinolone Acetonide Other / unclassified 40 mg Other